HEADER IMMUNE SYSTEM 21-JUN-12 4AYI TITLE STRUCTURE OF A COMPLEX BETWEEN CCPS 6 AND 7 OF HUMAN COMPLEMENT FACTOR TITLE 2 H AND NEISSERIA MENINGITIDIS FHBP VARIANT 3 WILD TYPE COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT FACTOR H; COMPND 3 CHAIN: A, E; COMPND 4 FRAGMENT: CCPS 6 AND 7, RESIDUES 321-443; COMPND 5 SYNONYM: H FACTOR 1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: LIPOPROTEIN GNA1870 CCOMPND 7; COMPND 9 CHAIN: D; COMPND 10 FRAGMENT: RESIDUES 32-281; COMPND 11 SYNONYM: FACTOR H BINDING PROTEIN; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 VARIANT: HIS402 POLYMORPHISM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 37762; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: B; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: B834(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET-14B; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: NEISSERIA MENINGITIDIS MC58; SOURCE 14 ORGANISM_TAXID: 122586; SOURCE 15 VARIANT: P28; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 37762; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: B; SOURCE 19 EXPRESSION_SYSTEM_VARIANT: B834(DE3); SOURCE 20 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 21 EXPRESSION_SYSTEM_PLASMID: PET-21A KEYWDS IMMUNE SYSTEM, ANTIGENS EXPDTA X-RAY DIFFRACTION AUTHOR S.JOHNSON,L.TAN,S.VAN DER VEEN,J.CAESAR,E.GOICOECHEA DE JORGE, AUTHOR 2 R.J.EVERETT,X.BAI,R.M.EXLEY,P.N.WARD,N.RUIVO,K.TRIVEDI,E.CUMBER, AUTHOR 3 R.JONES,L.NEWHAM,D.STAUNTON,R.BORROW,M.PICKERING,S.M.LEA,C.M.TANG REVDAT 4 20-DEC-23 4AYI 1 REMARK REVDAT 3 25-MAR-15 4AYI 1 TITLE SOURCE JRNL REVDAT 2 21-NOV-12 4AYI 1 JRNL REMARK REVDAT 1 07-NOV-12 4AYI 0 JRNL AUTH S.JOHNSON,L.TAN,S.VAN DER VEEN,J.CAESAR, JRNL AUTH 2 E.GOICOECHEA DE JORGE,R.J.HARDING,X.BAI,R.M.EXLEY,P.N.WARD, JRNL AUTH 3 N.RUIVO,K.TRIVEDI,E.CUMBER,R.JONES,L.NEWHAM,D.STAUNTON, JRNL AUTH 4 R.UFRET-VINCENTY,R.BORROW,M.C.PICKERING,S.M.LEA,C.M.TANG JRNL TITL DESIGN AND EVALUATION OF MENINGOCOCCAL VACCINES THROUGH JRNL TITL 2 STRUCTURE-BASED MODIFICATION OF HOST AND PATHOGEN MOLECULES. JRNL REF PLOS PATHOG. V. 8 2981 2012 JRNL REFN ISSN 1553-7366 JRNL PMID 23133374 JRNL DOI 10.1371/JOURNAL.PPAT.1002981 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 27148 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1362 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.09 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2611 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2639 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2486 REMARK 3 BIN R VALUE (WORKING SET) : 0.2623 REMARK 3 BIN FREE R VALUE : 0.2934 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.79 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 125 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3805 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 4 REMARK 3 SOLVENT ATOMS : 204 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.81180 REMARK 3 B22 (A**2) : -7.81180 REMARK 3 B33 (A**2) : 15.62350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.345 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.331 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.230 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.301 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.225 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.924 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3923 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5317 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1316 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 98 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 571 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3923 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 488 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4292 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.04 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.07 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NUMBER OF RESRAINT LIBRARIES USED : 8 REMARK 3 IDEAL-DIST CONTACT TERM CONTACT SETUP. ALL ATOMS HAVE CCP4 ATOM REMARK 4 REMARK 4 4AYI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1290052966. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-NOV-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97932 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27284 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 57.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 12.80 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 13.70 REMARK 200 R MERGE FOR SHELL (I) : 0.66000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2W81 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M IMIDAZOLE PH 6 20% PEG 4000, PH REMARK 280 6.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 181.52500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 28.56500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 28.56500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.76250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 28.56500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 28.56500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 272.28750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 28.56500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 28.56500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 90.76250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 28.56500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 28.56500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 272.28750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 181.52500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 319 REMARK 465 GLY A 320 REMARK 465 THR A 321 REMARK 465 LEU A 322 REMARK 465 LYS A 323 REMARK 465 MET D 61 REMARK 465 GLY D 62 REMARK 465 PRO D 63 REMARK 465 ASP D 64 REMARK 465 SER D 65 REMARK 465 ASP D 66 REMARK 465 ARG D 67 REMARK 465 LEU D 68 REMARK 465 GLN D 69 REMARK 465 GLN D 70 REMARK 465 ARG D 71 REMARK 465 ARG D 72 REMARK 465 VAL D 73 REMARK 465 ALA D 74 REMARK 465 ALA D 75 REMARK 465 ASP D 76 REMARK 465 ILE D 77 REMARK 465 GLY D 78 REMARK 465 THR D 79 REMARK 465 GLY D 80 REMARK 465 GLU D 322 REMARK 465 HIS D 323 REMARK 465 HIS D 324 REMARK 465 HIS D 325 REMARK 465 HIS D 326 REMARK 465 HIS D 327 REMARK 465 HIS D 328 REMARK 465 MET E 319 REMARK 465 GLY E 320 REMARK 465 THR E 321 REMARK 465 LEU E 322 REMARK 465 LYS E 323 REMARK 465 PRO E 324 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 370 -166.08 -168.12 REMARK 500 ASN A 399 32.36 -98.21 REMARK 500 CYS A 442 78.51 -101.15 REMARK 500 ASP D 226 76.09 -151.37 REMARK 500 HIS E 360 -5.47 83.18 REMARK 500 ASP E 370 -165.35 -166.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "DC" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO D 1322 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FHC RELATED DB: PDB REMARK 900 C3D AND HEPARIN BINDING COMPLEMENT FACTOR H DOMAINS SCR19-20 REMARK 900 RELATED ID: 1HAQ RELATED DB: PDB REMARK 900 FOUR MODELS OF HUMAN FACTOR H DETERMINED BY SOLUTION SCATTERING REMARK 900 CURVE-FITTING AND HOMOLOGY MODELLING REMARK 900 RELATED ID: 1HCC RELATED DB: PDB REMARK 900 RELATED ID: 1HFH RELATED DB: PDB REMARK 900 FACTOR H, 15TH AND 16TH C-MODULE PAIR (NMR, MINIMIZED AVERAGED REMARK 900 STRUCTURE) REMARK 900 RELATED ID: 1HFI RELATED DB: PDB REMARK 900 FACTOR H, 15TH C-MODULE PAIR (NMR, MINIMIZED AVERAGED STRUCTURE) REMARK 900 RELATED ID: 1KOV RELATED DB: PDB REMARK 900 HOMOLOGY MODEL OF HUMAN FACTOR H SCRS 6 AND 7 REMARK 900 RELATED ID: 2G7I RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN COMPLEMENT FACTOR H CARBOXYL TERMINALDOMAINS 19- REMARK 900 20: A BASIS FOR ATYPICAL HEMOLYTIC UREMICSYNDROME REMARK 900 RELATED ID: 2JGW RELATED DB: PDB REMARK 900 STRUCTURE OF CCP MODULE 7 OF COMPLEMENT FACTOR H - THE AMD AT RISK REMARK 900 VARIENT (402H) REMARK 900 RELATED ID: 2JGX RELATED DB: PDB REMARK 900 STRUCTURE OF CCP MODULE 7 OF COMPLEMENT FACTOR H - THE AMD NOT AT REMARK 900 RISK VARIENT (402Y) REMARK 900 RELATED ID: 2UWN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COMPLEMENT FACTOR H, SCR DOMAINS 6-8 REMARK 900 (H402 RISK VARIANT), IN COMPLEX WITH LIGAND. REMARK 900 RELATED ID: 2V8E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COMPLEMENT FACTOR H, SCR DOMAINS 6-8 REMARK 900 (H402 RISK VARIANT), IN COMPLEX WITH LIGAND. REMARK 900 RELATED ID: 2W80 RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN NEISSERIA MENINGITIDIS FACTOR H REMARK 900 BINDING PROTEIN AND CCPS 6-7 OF HUMAN COMPLEMENT FACTOR H REMARK 900 RELATED ID: 2W81 RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN NEISSERIA MENINGITIDIS FACTOR H REMARK 900 BINDING PROTEIN AND CCPS 6-7 OF HUMAN COMPLEMENT FACTOR H REMARK 900 RELATED ID: 2WII RELATED DB: PDB REMARK 900 COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4 REMARK 900 RELATED ID: 2XQW RELATED DB: PDB REMARK 900 STRUCTURE OF FACTOR H DOMAINS 19-20 IN COMPLEX WITH COMPLEMENT C3D REMARK 900 RELATED ID: 4AYD RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN CCPS 6 AND 7 OF HUMAN COMPLEMENT REMARK 900 FACTOR H AND NEISSERIA MENINGITIDIS FHBP VARIANT 1 R106A MUTANT REMARK 900 RELATED ID: 4AYE RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN CCPS 6 AND 7 OF HUMAN COMPLEMENT REMARK 900 FACTOR H AND NEISSERIA MENINGITIDIS FHBP VARIANT 1 E283AE304A MUTANT REMARK 900 RELATED ID: 4AYM RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN CCPS 6 AND 7 OF HUMAN COMPLEMENT REMARK 900 FACTOR H AND NEISSERIA MENINGITIDIS FHBP VARIANT 3 P106A MUTANT REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS IS THE HIS402 POLYMORPHISM. MG AT THE START COME FROM REMARK 999 THE VECTOR. REMARK 999 DISCREPANCIES AT TERMINII ARE FROM VECTOR. THE SEQUENCE REMARK 999 HAS BEEN RENUMBERED TO MATCH THAT OF THE VARIANT 1 REMARK 999 SEQUENCE (PDBID 2W81) DBREF 4AYI A 321 443 UNP P08603 CFAH_HUMAN 321 443 DBREF 4AYI D 73 320 UNP Q19KF7 Q19KF7_NEIME 32 281 DBREF 4AYI E 321 443 UNP P08603 CFAH_HUMAN 321 443 SEQADV 4AYI MET A 319 UNP P08603 EXPRESSION TAG SEQADV 4AYI GLY A 320 UNP P08603 EXPRESSION TAG SEQADV 4AYI HIS A 402 UNP P08603 TYR 402 VARIANT SEQADV 4AYI MET D 61 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI GLY D 62 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI PRO D 63 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI ASP D 64 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI SER D 65 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI ASP D 66 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI ARG D 67 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI LEU D 68 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI GLN D 69 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI GLN D 70 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI ARG D 71 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI ARG D 72 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI LEU D 321 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI GLU D 322 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI HIS D 323 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI HIS D 324 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI HIS D 325 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI HIS D 326 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI HIS D 327 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI HIS D 328 UNP Q19KF7 EXPRESSION TAG SEQADV 4AYI MET E 319 UNP P08603 EXPRESSION TAG SEQADV 4AYI GLY E 320 UNP P08603 EXPRESSION TAG SEQADV 4AYI HIS E 402 UNP P08603 TYR 402 VARIANT SEQRES 1 A 125 MET GLY THR LEU LYS PRO CYS ASP TYR PRO ASP ILE LYS SEQRES 2 A 125 HIS GLY GLY LEU TYR HIS GLU ASN MET ARG ARG PRO TYR SEQRES 3 A 125 PHE PRO VAL ALA VAL GLY LYS TYR TYR SER TYR TYR CYS SEQRES 4 A 125 ASP GLU HIS PHE GLU THR PRO SER GLY SER TYR TRP ASP SEQRES 5 A 125 HIS ILE HIS CYS THR GLN ASP GLY TRP SER PRO ALA VAL SEQRES 6 A 125 PRO CYS LEU ARG LYS CYS TYR PHE PRO TYR LEU GLU ASN SEQRES 7 A 125 GLY TYR ASN GLN ASN HIS GLY ARG LYS PHE VAL GLN GLY SEQRES 8 A 125 LYS SER ILE ASP VAL ALA CYS HIS PRO GLY TYR ALA LEU SEQRES 9 A 125 PRO LYS ALA GLN THR THR VAL THR CYS MET GLU ASN GLY SEQRES 10 A 125 TRP SER PRO THR PRO ARG CYS ILE SEQRES 1 D 270 MET GLY PRO ASP SER ASP ARG LEU GLN GLN ARG ARG VAL SEQRES 2 D 270 ALA ALA ASP ILE GLY THR GLY LEU ALA ASP ALA LEU THR SEQRES 3 D 270 ALA PRO LEU ASP HIS LYS ASP LYS GLY LEU LYS SER LEU SEQRES 4 D 270 THR LEU GLU ASP SER ILE PRO GLN ASN GLY THR LEU THR SEQRES 5 D 270 LEU SER ALA GLN GLY ALA GLU LYS THR PHE LYS ALA GLY SEQRES 6 D 270 ASP LYS ASP ASN SER LEU ASN THR GLY LYS LEU LYS ASN SEQRES 7 D 270 ASP LYS ILE SER ARG PHE ASP PHE VAL GLN LYS ILE GLU SEQRES 8 D 270 VAL ASP GLY GLN THR ILE THR LEU ALA SER GLY GLU PHE SEQRES 9 D 270 GLN ILE TYR LYS GLN ASN HIS SER ALA VAL VAL ALA LEU SEQRES 10 D 270 GLN ILE GLU LYS ILE ASN ASN PRO ASP LYS THR ASP SER SEQRES 11 D 270 LEU ILE ASN GLN ARG SER PHE LEU VAL SER GLY LEU GLY SEQRES 12 D 270 GLY GLU HIS THR ALA PHE ASN GLN LEU PRO GLY GLY LYS SEQRES 13 D 270 ALA GLU TYR HIS GLY LYS ALA PHE SER SER ASP ASP PRO SEQRES 14 D 270 ASN GLY ARG LEU HIS TYR SER ILE ASP PHE THR LYS LYS SEQRES 15 D 270 GLN GLY TYR GLY ARG ILE GLU HIS LEU LYS THR LEU GLU SEQRES 16 D 270 GLN ASN VAL GLU LEU ALA ALA ALA GLU LEU LYS ALA ASP SEQRES 17 D 270 GLU LYS SER HIS ALA VAL ILE LEU GLY ASP THR ARG TYR SEQRES 18 D 270 GLY SER GLU GLU LYS GLY THR TYR HIS LEU ALA LEU PHE SEQRES 19 D 270 GLY ASP ARG ALA GLN GLU ILE ALA GLY SER ALA THR VAL SEQRES 20 D 270 LYS ILE GLY GLU LYS VAL HIS GLU ILE GLY ILE ALA GLY SEQRES 21 D 270 LYS GLN LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 E 125 MET GLY THR LEU LYS PRO CYS ASP TYR PRO ASP ILE LYS SEQRES 2 E 125 HIS GLY GLY LEU TYR HIS GLU ASN MET ARG ARG PRO TYR SEQRES 3 E 125 PHE PRO VAL ALA VAL GLY LYS TYR TYR SER TYR TYR CYS SEQRES 4 E 125 ASP GLU HIS PHE GLU THR PRO SER GLY SER TYR TRP ASP SEQRES 5 E 125 HIS ILE HIS CYS THR GLN ASP GLY TRP SER PRO ALA VAL SEQRES 6 E 125 PRO CYS LEU ARG LYS CYS TYR PHE PRO TYR LEU GLU ASN SEQRES 7 E 125 GLY TYR ASN GLN ASN HIS GLY ARG LYS PHE VAL GLN GLY SEQRES 8 E 125 LYS SER ILE ASP VAL ALA CYS HIS PRO GLY TYR ALA LEU SEQRES 9 E 125 PRO LYS ALA GLN THR THR VAL THR CYS MET GLU ASN GLY SEQRES 10 E 125 TRP SER PRO THR PRO ARG CYS ILE HET EDO D1322 4 HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 4 EDO C2 H6 O2 FORMUL 5 HOH *204(H2 O) HELIX 1 1 HIS A 337 ARG A 342 1 6 HELIX 2 2 PRO A 343 PHE A 345 5 3 HELIX 3 3 LEU A 422 GLN A 426 5 5 HELIX 4 4 LEU D 81 ALA D 87 1 7 HELIX 5 5 LEU D 101 ILE D 105 5 5 HELIX 6 6 ILE D 105 ASN D 108 5 4 HELIX 7 7 GLY D 131 LEU D 133 5 3 HELIX 8 8 PHE D 206 LEU D 209 5 4 HELIX 9 9 HIS E 337 ARG E 342 1 6 HELIX 10 10 PRO E 343 PHE E 345 5 3 HELIX 11 11 LEU E 422 GLN E 426 5 5 SHEET 1 AA 4 GLY A 333 LEU A 335 0 SHEET 2 AA 4 TYR A 352 CYS A 357 -1 O TYR A 356 N GLY A 334 SHEET 3 AA 4 TRP A 369 THR A 375 -1 O ASP A 370 N TYR A 355 SHEET 4 AA 4 GLY A 378 SER A 380 -1 O GLY A 378 N THR A 375 SHEET 1 AB 3 PHE A 361 GLU A 362 0 SHEET 2 AB 3 LEU A 386 TYR A 390 -1 O LEU A 386 N GLU A 362 SHEET 3 AB 3 LYS A 405 VAL A 407 -1 O PHE A 406 N CYS A 389 SHEET 1 AC 3 SER A 411 ASP A 413 0 SHEET 2 AC 3 THR A 428 MET A 432 -1 O VAL A 429 N ILE A 412 SHEET 3 AC 3 GLY A 435 SER A 437 -1 O GLY A 435 N MET A 432 SHEET 1 DA 2 SER D 98 LEU D 99 0 SHEET 2 DA 2 LEU D 128 ASN D 129 -1 N LEU D 128 O LEU D 99 SHEET 1 DB 6 ALA D 118 LYS D 123 0 SHEET 2 DB 6 THR D 110 ALA D 115 -1 O LEU D 111 N PHE D 122 SHEET 3 DB 6 ILE D 138 VAL D 149 -1 O ASP D 142 N SER D 114 SHEET 4 DB 6 GLN D 152 LYS D 165 -1 O GLN D 152 N VAL D 149 SHEET 5 DB 6 SER D 169 ASN D 180 -1 O VAL D 171 N TYR D 164 SHEET 6 DB 6 LEU D 188 GLY D 201 -1 O ILE D 189 N ILE D 179 SHEET 1 DC 9 LYS D 214 SER D 223 0 SHEET 2 DC 9 ASP D 226 ASP D 236 -1 O ASP D 226 N SER D 223 SHEET 3 DC 9 GLN D 241 GLU D 247 -1 O GLN D 241 N ASP D 236 SHEET 4 DC 9 VAL D 256 ALA D 265 -1 O VAL D 256 N ILE D 246 SHEET 5 DC 9 ALA D 271 TYR D 279 -1 O VAL D 272 N LYS D 264 SHEET 6 DC 9 GLU D 282 PHE D 292 -1 O GLU D 282 N TYR D 279 SHEET 7 DC 9 GLU D 298 ILE D 307 -1 O GLU D 298 N PHE D 292 SHEET 8 DC 9 LYS D 310 LYS D 319 -1 O LYS D 310 N ILE D 307 SHEET 9 DC 9 LYS D 214 SER D 223 -1 O HIS D 218 N LYS D 319 SHEET 1 EA 4 GLY E 333 LEU E 335 0 SHEET 2 EA 4 TYR E 352 CYS E 357 -1 O TYR E 356 N GLY E 334 SHEET 3 EA 4 TRP E 369 THR E 375 -1 O ASP E 370 N TYR E 355 SHEET 4 EA 4 GLY E 378 SER E 380 -1 O GLY E 378 N THR E 375 SHEET 1 EB 3 PHE E 361 GLU E 362 0 SHEET 2 EB 3 LEU E 386 TYR E 390 -1 O LEU E 386 N GLU E 362 SHEET 3 EB 3 LYS E 405 VAL E 407 -1 O PHE E 406 N CYS E 389 SHEET 1 EC 3 SER E 411 ASP E 413 0 SHEET 2 EC 3 THR E 428 MET E 432 -1 O VAL E 429 N ILE E 412 SHEET 3 EC 3 GLY E 435 SER E 437 -1 O GLY E 435 N MET E 432 SSBOND 1 CYS A 325 CYS A 374 1555 1555 2.04 SSBOND 2 CYS A 357 CYS A 385 1555 1555 2.05 SSBOND 3 CYS A 389 CYS A 431 1555 1555 2.05 SSBOND 4 CYS A 416 CYS A 442 1555 1555 2.04 SSBOND 5 CYS E 325 CYS E 374 1555 1555 2.04 SSBOND 6 CYS E 357 CYS E 385 1555 1555 2.06 SSBOND 7 CYS E 389 CYS E 431 1555 1555 2.06 SSBOND 8 CYS E 416 CYS E 442 1555 1555 2.04 CISPEP 1 PHE A 345 PRO A 346 0 4.41 CISPEP 2 SER A 380 PRO A 381 0 -0.13 CISPEP 3 SER A 437 PRO A 438 0 -3.79 CISPEP 4 GLY D 95 LEU D 96 0 -0.78 CISPEP 5 PHE E 345 PRO E 346 0 1.47 CISPEP 6 SER E 380 PRO E 381 0 2.35 CISPEP 7 SER E 437 PRO E 438 0 -4.25 SITE 1 AC1 6 ARG A 341 HOH A2015 HOH A2027 THR D 286 SITE 2 AC1 6 HIS D 288 SER D 302 CRYST1 57.130 57.130 363.050 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017504 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017504 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002754 0.00000 MTRIX1 1 -0.888450 0.100240 -0.447890 -21.24986 1 MTRIX2 1 -0.221650 -0.948230 0.227460 -33.24406 1 MTRIX3 1 -0.401900 0.301360 0.864670 40.27188 1